1. Home
  2. EARN vs PROF Comparison

EARN vs PROF Comparison

Compare EARN & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EARN
  • PROF
  • Stock Information
  • Founded
  • EARN 2012
  • PROF N/A
  • Country
  • EARN United States
  • PROF Canada
  • Employees
  • EARN N/A
  • PROF N/A
  • Industry
  • EARN Real Estate Investment Trusts
  • PROF Medical/Dental Instruments
  • Sector
  • EARN Real Estate
  • PROF Health Care
  • Exchange
  • EARN Nasdaq
  • PROF Nasdaq
  • Market Cap
  • EARN 189.7M
  • PROF 179.7M
  • IPO Year
  • EARN 2013
  • PROF N/A
  • Fundamental
  • Price
  • EARN $5.22
  • PROF $6.87
  • Analyst Decision
  • EARN Buy
  • PROF Strong Buy
  • Analyst Count
  • EARN 2
  • PROF 1
  • Target Price
  • EARN $5.88
  • PROF $11.00
  • AVG Volume (30 Days)
  • EARN 341.8K
  • PROF 72.9K
  • Earning Date
  • EARN 11-19-2025
  • PROF 11-13-2025
  • Dividend Yield
  • EARN 18.29%
  • PROF N/A
  • EPS Growth
  • EARN N/A
  • PROF N/A
  • EPS
  • EARN N/A
  • PROF N/A
  • Revenue
  • EARN $35,893,000.00
  • PROF $14,297,000.00
  • Revenue This Year
  • EARN N/A
  • PROF $60.07
  • Revenue Next Year
  • EARN $15.93
  • PROF $120.03
  • P/E Ratio
  • EARN N/A
  • PROF N/A
  • Revenue Growth
  • EARN 43.30
  • PROF 67.94
  • 52 Week Low
  • EARN $4.33
  • PROF $3.76
  • 52 Week High
  • EARN $6.99
  • PROF $8.75
  • Technical
  • Relative Strength Index (RSI)
  • EARN 49.70
  • PROF 70.64
  • Support Level
  • EARN $5.10
  • PROF $5.64
  • Resistance Level
  • EARN $5.32
  • PROF $6.73
  • Average True Range (ATR)
  • EARN 0.11
  • PROF 0.47
  • MACD
  • EARN 0.02
  • PROF 0.06
  • Stochastic Oscillator
  • EARN 59.23
  • PROF 92.67

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: